Outset Medical, Inc. Proceeds from Operating Activities
Outset Medical, Inc. (OM) reported Proceeds from Operating Activities of $25.70 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-08.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ProceedsFromOperatingActivities · last filed 2025-08-07
- Outset Medical, Inc. proceeds from operating activities for the quarter ending 2025-03-31 was $25.70M, a 44.01% decline year-over-year.
- Outset Medical, Inc. proceeds from operating activities for the quarter ending 2024-06-30 was $33.30M.
- Outset Medical, Inc. proceeds from operating activities for the quarter ending 2024-03-31 was $45.90M.
- Outset Medical, Inc. proceeds from operating activities for fiscal 2024 was $116.30M, a 11.49% decline from fiscal 2023.
- Outset Medical, Inc. proceeds from operating activities for fiscal 2023 was $131.40M, a 9.81% decline from fiscal 2022.
- Outset Medical, Inc. proceeds from operating activities for fiscal 2022 was $145.70M.
| Period end | Proceeds from Operating Activities 3 month | Proceeds from Operating Activities 6 month | Proceeds from Operating Activities 12 month |
|---|---|---|---|
| 2025-03-31 | $25.70M 10-Q · filed 2025-05-08 | ||
| 2024-12-31 | $116.30M 10-K · filed 2025-02-28 | ||
| 2024-06-30 | $33.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $79.20M 10-Q · filed 2025-08-07 | |
| 2024-03-31 | $45.90M 10-Q · filed 2025-05-08 | ||
| 2023-12-31 | $131.40M 10-K · filed 2025-02-28 | ||
| 2022-12-31 | $145.70M 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |